-

Dr. Hongzhou Lu: NAD Management is Key for HIV Patients, Not Just Changing Medication
-

Dr. Wei Cao: Focus on Managing HIV Complications, Further Improving Patient Survival
-

SGBCC International Dialogue| Dr. Li Zhu & Dr. Giuseppe Curigliano Discuss the Need for Adjuvant Therapy After Achieving pCR in Neoadjuvant Treatment
-

Dr. Jian Zhang Discusses with Dr. Harbeck: Is Chemotherapy Necessary for ER+/HER2- Breast Cancer Patients with Low Genetic Risk but High Clinical Risk
-
Unresolved Issues in Pediatric Hepatitis B Treatment Guidelines
-
The Treatment and Clinical Cure of Childhood Hepatitis B
-

From “Clinical Cure” to “Disease Cure” – The Long-term Treatment of Chronic Hepatitis B
-

Dr. Lai Wei talk about the Renaming of NAFLD to MASLD, Exploration of the Hepatitis B Research Paradigm, and Highlights from the 2023 EASL Congress
-

Doctor Tarik Asselah: Beyond Liver Cancer, Viral Hepatitis Is Also Linked to Some Extrahepatic Malignancies
-

Doctor Tom Hemming Karlsen Explains the EASL- The Lancet Liver Commission Initiative to Improve European Liver Health and Its Implementation Progress
-

Treatment Options for Early Liver Cancer, Strategies for Preventing Recurrence, and the Application of New Molecular Technologies in Tumour
-

Dr. Jing Zhang: Team’s 7 Achievements in the Fields of Fatty Liver, Cirrhosis, and Hepatitis C, Research Insights, and Future Directions